$7.00
-0.36-4.89%
Pre-Market: Jul 18, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Oncternal Therapeutics
ONCTNASDAQ
Oncternal Therapeutics (NASDAQ:ONCT) Stock, Earnings Estimates, EPS, And Revenue
Oncternal Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$-3.100
Quarterly Revenue Estimate
$240K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Oncternal Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics | -$3.00 | -$3.10 | — | — | $106.00K | $240.00K | — | — | 08/08/2024 | Get Alert |
| ONCT | Oncternal Therapeutics | -$3.93 | -$2.88 | -$2.83 | 1.74% | $203.00K | $180.00K | $569.00K | 216.11% | 05/09/2024 | Get Alert |
| ONCT | Oncternal Therapeutics | -$4.00 | -$3.07 | -$3.11 | -1.30% | $171.00K | $140.00K | $297.00K | 112.14% | 03/07/2024 | Get Alert |
| ONCT | Oncternal Therapeutics | -$4.20 | -$2.80 | -$3.40 | -21.43% | $382.00K | $120.00K | $179.00K | 49.17% | 11/09/2023 | Get Alert |
| ONCT | Oncternal Therapeutics | -$4.60 | -$3.20 | -$3.00 | 6.25% | $191.00K | $200.00K | $106.00K | -47.00% | 08/10/2023 | Get Alert |
| ONCT | Oncternal Therapeutics | -$4.00 | -$4.00 | -$4.00 | 0.00% | $746.00K | $170.00K | $203.00K | 19.41% | 05/04/2023 | Get Alert |
| ONCT | Oncternal Therapeutics | -$3.20 | -$4.20 | -$4.00 | 4.76% | $556.00K | $330.00K | $171.00K | -48.18% | 03/09/2023 | Get Alert |
| ONCT | Oncternal Therapeutics | -$3.80 | -$4.80 | -$4.20 | 12.50% | $2.13M | $310.00K | $382.00K | 23.23% | 11/03/2022 | Get Alert |
| ONCT | Oncternal Therapeutics | -$3.20 | -$4.60 | -$4.60 | 0.00% | $883.00K | $460.00K | $191.00K | -58.48% | 08/09/2022 | Get Alert |
| ONCT | Oncternal Therapeutics | -$2.40 | -$4.00 | -$4.00 | 0.00% | $748.00K | $520.00K | $746.00K | 43.46% | 05/05/2022 | Get Alert |
| ONCT | Oncternal Therapeutics | -$1.80 | — | -$3.20 | — | $1.59M | — | $556.00K | — | 03/10/2022 | Get Alert |
| ONCT | Oncternal Therapeutics | -$4.40 | -$3.20 | -$3.80 | -18.75% | $585.00K | $1.30M | $2.13M | 63.69% | 11/04/2021 | Get Alert |
| ONCT | Oncternal Therapeutics | -$6.80 | -$2.80 | -$3.20 | -14.29% | $623.00K | $1.09M | $883.00K | -18.99% | 08/05/2021 | Get Alert |
| ONCT | Oncternal Therapeutics | -$6.20 | -$2.00 | -$2.40 | -20.00% | $578.00K | $1.11M | $748.00K | -32.61% | 05/06/2021 | Get Alert |
| ONCT | Oncternal Therapeutics | -$5.40 | -$3.60 | -$1.80 | 50.00% | $737.00K | $590.00K | $1.59M | 169.15% | 03/11/2021 | Get Alert |
| ONCT | Oncternal Therapeutics | -$6.40 | — | -$4.40 | — | $544.00K | — | $585.00K | — | 11/04/2020 | Get Alert |
| ONCT | Oncternal Therapeutics | -$67.60 | — | -$6.80 | — | $674.00K | — | $623.00K | — | 08/06/2020 | Get Alert |
| ONCT | Oncternal Therapeutics | — | — | -$6.20 | — | — | — | $578.00K | — | 05/07/2020 | Get Alert |
| ONCT | Oncternal Therapeutics | -$4.20 | — | -$5.40 | — | $477.00K | — | $737.00K | — | 03/16/2020 | Get Alert |
| ONCT | Oncternal Therapeutics | — | — | -$6.40 | — | $329.00K | — | $544.00K | — | 11/07/2019 | Get Alert |
| ONCT | Oncternal Therapeutics | — | — | -$67.60 | — | — | — | $674.00K | — | 08/08/2019 | Get Alert |
Oncternal Therapeutics (ONCT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-2.83 | $-2.88 | 1.74 % |
| Dec 2023 | 2024-03-07 | $-3.11 | $-3.07 | -1.30 % |
| Sep 2023 | 2023-11-09 | $-3.40 | $-2.80 | -21.4 % |
| Jun 2023 | 2023-08-10 | $-3.00 | $-3.20 | 6.25 % |
Oncternal Therapeutics (ONCT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $569.00K | $180.00K | 216.1 % |
| Dec 2023 | 2024-03-07 | $297.00K | $140.00K | 112.1 % |
| Sep 2023 | 2023-11-09 | $179.00K | $120.00K | 49.2 % |
| Jun 2023 | 2023-08-10 | $106.00K | $200.00K | -47.0 % |
FAQ
When is Oncternal Therapeutics (NASDAQ:ONCT) reporting earnings?
Oncternal Therapeutics (ONCT) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Oncternal Therapeutics (NASDAQ:ONCT)?
The Actual EPS was $-2.83, which beat the estimate of $-2.88.
What were Oncternal Therapeutics’s (NASDAQ:ONCT) revenues?
The Actual Revenue was $569K, which beat the estimate of $180K.
Browse earnings estimates, EPS, and revenue on all stocks.